Arsenic Makes Its Mark: Using Biomarkers to Track Noncancer Respiratory Effects
2008

Tracking Noncancer Respiratory Effects of Arsenic

Sample size: 241 publication Evidence: moderate

Author Information

Author(s): Mead M. Nathaniel

Primary Institution: National Institute of Environmental Health Sciences

Hypothesis

Can biomarkers like serum CC16 help identify noncancer respiratory effects of arsenic exposure?

Conclusion

Serum CC16 may serve as a useful biomarker for early respiratory damage from arsenic, particularly in individuals with skin lesions.

Supporting Evidence

  • Individuals with skin lesions consumed more arsenic than those without.
  • There was a significant inverse association of CC16 with urinary arsenic in individuals with skin lesions.
  • Individuals with better arsenic methylation capacity may be less susceptible to respiratory effects.

Takeaway

Drinking water with arsenic can hurt your lungs, and scientists are looking at a special blood test to see how bad it is.

Methodology

The study examined serum CC16 levels in relation to arsenic exposure in a population of nonsmoking individuals.

Potential Biases

Interviewer bias could influence the assessment of respiratory symptoms.

Limitations

The study may be affected by interviewer bias due to visible skin lesions in participants.

Participant Demographics

241 nonsmoking individuals exposed to arsenic-laden drinking water in Araihazar, Bangladesh.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication